PR Newswire - Key Milestone Achieved: NDA for Sumecigrel Capsule...
NANJING, China, June 26, 2026 /PRNewswire/ -- Recently, the NDA for Sumecigrel Capsule (formerly known as Vicagrel), a Class 1 innovative antiplatelet drug developed by Jiangsu Vcare PharmaTech Co.,Lt...
Read More

ภาษาไทย
English